- Home
- TNXP vs ALMU Comparison
TNXP vs ALMU Comparison
Compare TNXP & ALMU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TNXP
- ALMU
- Stock Information
- Founded
- TNXP 2007
- ALMU 2019
- Country
- TNXP United States
- ALMU United States
- Employees
- TNXP N/A
- ALMU N/A
- Industry
- TNXP Biotechnology: Pharmaceutical Preparations
- ALMU Semiconductors
- Sector
- TNXP Health Care
- ALMU Technology
- Exchange
- TNXP Nasdaq
- ALMU Nasdaq
- Market Cap
- TNXP 335.6M
- ALMU 295.5M
- IPO Year
- TNXP N/A
- ALMU N/A
- Fundamental
- Price
- TNXP $28.35
- ALMU $15.93
- Analyst Decision
- TNXP Buy
- ALMU Strong Buy
- Analyst Count
- TNXP 1
- ALMU 2
- Target Price
- TNXP $70.00
- ALMU $25.50
- AVG Volume (30 Days)
- TNXP 1.2M
- ALMU 316.0K
- Earning Date
- TNXP 11-11-2025
- ALMU 09-09-2025
- Dividend Yield
- TNXP N/A
- ALMU N/A
- EPS Growth
- TNXP N/A
- ALMU N/A
- EPS
- TNXP N/A
- ALMU N/A
- Revenue
- TNXP $9,831,000.00
- ALMU $4,665,000.00
- Revenue This Year
- TNXP $14.79
- ALMU $60.71
- Revenue Next Year
- TNXP $933.49
- ALMU $107.42
- P/E Ratio
- TNXP N/A
- ALMU N/A
- Revenue Growth
- TNXP N/A
- ALMU 407.62
- 52 Week Low
- TNXP $6.76
- ALMU $2.50
- 52 Week High
- TNXP $130.00
- ALMU $25.88
- Technical
- Relative Strength Index (RSI)
- TNXP 41.38
- ALMU 43.87
- Support Level
- TNXP $26.89
- ALMU $14.51
- Resistance Level
- TNXP $29.19
- ALMU $18.78
- Average True Range (ATR)
- TNXP 2.18
- ALMU 1.95
- MACD
- TNXP 0.39
- ALMU -0.20
- Stochastic Oscillator
- TNXP 56.46
- ALMU 28.14
About TNXP Tonix Pharmaceuticals Holding Corp.
Tonix Pharmaceuticals Holding Corp is a biopharmaceutical company focused on developing, licensing and commercializing therapeutics to treat and prevent human disease and alleviate suffering. Tonix's development portfolio is focused on central nervous system (CNS) disorders. The company's immunology development portfolio consists of biologics to address organ transplant rejection, autoimmunity and cancer, including TNX-1500, which is a humanized monoclonal antibody targeting CD40-ligand (CD40L or CD154) being developed for the prevention of allograft rejection and for the treatment of autoimmune diseases. Tonix also has product candidates in development in the areas of rare disease and infectious disease.
About ALMU Aeluma Inc. Common Stock
Aeluma Inc is a semiconductor company specializing in sensors and communications. It is developing sensor technology for mobile devices and vehicles. The company develops novel optoelectronic devices for sensing and communications applications. The company manufactures devices using high-performance compound semiconductor materials on large-diameter substrates that are commonly used to manufacture mass-market microelectronics. The applications include mobile, automotive, AI, defense & aerospace, communication, AR/VR and quantum computing.